Find disease awareness content and relevant supporting materials

Latest data and clinical guidance

The cardiovascular metabolism (CVM) Learning Zone hosted on Medthority.com features over 70 expert opinion videos covering type 2 diabetes and hypertension.

These EAU guidelines provide evidence‑based recommendations for the diagnosis, treatment, and prevention of urological infections. They cover common and complex infections across urological practice to support effective and safe patient management.

The EAU PCa Guidelines were first published in 2001. Standard procedure for EAU Guidelines includes an annual assessment of newly published literature in the field to guide future updates. This 2025 PCa Guidelines present a limited update of the 2024 publication.

The European Association of Urology (EAU) presents updated guidelines on the evidence-based management of urolithiasis. These recommendations address urinary tract stone treatment, including bladder stones, and consider geographic variations in care delivery.

The 2024 European Society of Hypertension (ESH) Clinical Practice Guidelines offer a comprehensive and concise approach to managing arterial hypertension. Endorsed by leading medical organizations, these guidelines provide essential strategies for effective hypertension management, ensuring the best outcomes for patients.

Read the transcript of an expert interview on what’s new in the forthcoming European hidradenitis suppurativa guidelines, with Aikaterini Liakou.

These EAU guidelines provide evidence‑based recommendations for the diagnosis, staging, treatment, and follow‑up of testicular cancer. They aim to support optimal clinical decision‑making across disease stages and risk groups.

Read about, and access, the current guidelines for the management of psoriasis developed by the AAD, EADV, the British Association of Dermatologists and more.

These Royal College of Ophthalmologists guidelines outline current best practice for the diagnosis and management of retinal vein occlusion. They incorporate advances in imaging and updated evidence on intravitreal therapies to support optimal clinical care pathways for patients with RVO.